{"document_type": "article", "byline": {"contributor": "", "person": [{"role": "reported", "firstname": "Gretchen", "organization": "", "rank": 1, "lastname": "MORGENSON"}], "original": "By GRETCHEN MORGENSON"}, "news_desk": "SundayBusiness", "slideshow_credits": null, "abstract": "Gretchen Morgenson Fair Game column explains second way Valeant Pharmaceuticals International benefited from its highly questionable drug pricing policies; notes firm's excessive drug price increases also inflated its operating cash flow through so-called price appreciation credits, practice in which company receives credit from wholesalers reflecting impact of that price increase on those wholesalers' current inventory. ", "multimedia": [{"type": "image", "url": "images/2016/07/31/business/31gret1/31gret1-thumbWide.jpg", "legacy": {"wide": "images/2016/07/31/business/31gret1/31gret1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/07/31/business/31gret1/31gret1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/07/31/business/31gret1/31gret1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/07/31/business/31gret1/31gret1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/07/31/business/31gret1/31gret1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"kicker": "Fair Game", "content_kicker": "Fair Game", "print_headline": "Two Bumps From One Price Jump", "main": "How Valeant Cashed In Twice on Higher Drug Prices"}, "print_page": "1", "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "4", "name": "persons"}], "snippet": "It wasn\u2019t just soaring drug prices that helped Valeant Pharmaceuticals\u2019 cash flow. A credit for inventories at those higher prices also plumped the figures....", "source": "The New York Times", "lead_paragraph": "It wasn\u2019t just soaring drug prices that helped Valeant Pharmaceuticals\u2019 cash flow. A credit for inventories at those higher prices also plumped the figures.", "word_count": "1167", "pub_date": "2016-07-29T17:25:32+0000", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/07/31/business/how-valeant-cashed-in-twice-on-higher-drug-prices.html", "_id": "579b918e38f0d83c0fcf7790"}